MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Liraglutide once daily versus placebo in Parkinson’s disease: a randomized, double-blind, placebo-controlled trial

    T. Wu, C. Bresee, J. Wertheimer, E. Hogg, C. Malatt, E. Tan, H. Pomeroy, G. Obialisi, M. Tagliati (Los Angeles, USA)

    Objective: To test safety and efficacy of the glucagon-like peptide 1 (GLP-1) agonist liraglutide in idiopathic Parkinson’s disease (PD). Background: Insulin resistance (IR) may play…
  • 2022 International Congress

    Prepulse inhibition of the blink reflex in functional movement disorders

    L. Nováková, P. Sojka, D. Voženílek, E. Růžička, T. Serranová (Praha, Czech Republic)

    Objective: To assess the influence of directed attention on prepulse inhibition (PPI) of the blink reflex in patients with functional movement disorders (FMD) and healthy…
  • 2022 International Congress

    Emotion Recognition and Risk-Taking Behaviour in Early Parkinson’s Disease

    A. Slomp, D. de Waard, S. Vander Zee, S. Slingerland, J. Boertien, J. Spikman, T. van Laar, R. Huitema (Groningen, Netherlands)

    Objective: To assess the association between facial emotion recognition and traffic-related risk-taking behaviour in early Parkinson’s Disease (PD) patients. Background: Risk-taking behaviour is an important…
  • 2022 International Congress

    Spectrum of Movement Disorder Emergencies in a Tertiary Care Centre in India: A prospective Observational Study

    A. Bhoyar, R. Yadav, P. Pal, R. Mahale, N. Kamble, V. Holla (BANGLORE, India)

    Objective: The objective of this study was to study the clinical phenomenology, investigational characteristics, radiological findings and the outcomes at discharge of patients presenting with…
  • 2022 International Congress

    Initial Postmarketing Real World Experience with directSTIM™ DBS System: A Case Series

    W. Polanski, S. Sobottka, V. Coenen, A. Frank, B. Falkenburger (Dresden, Germany)

    Objective: In this study we report the first three cases of a new, CE-marked system for deep brain stimulation. Background: The PMCF study is a…
  • 2022 International Congress

    Patient Advisory Boards: A Model for Patient Engagement in Parkinson’s Disease Comparative Effectiveness Research

    K. Schroeder, C. Gallagher, M. Armstrong, M. Carnie, C. Evers, J. Fleisher, B. Kluger, J. Lamb, S. Seshadri, L. Wilson, M. Feeney, P. Davies (New York, USA)

    Objective: To build a replicable, sustainable model of patient engagement in Parkinson’s disease (PD) comparative effectiveness research (CER) at academic research centers through patient advisory…
  • 2022 International Congress

    Feasibility and efficacy of a multidisciplinary home-telehealth intervention program to reduce falls and improve quality of life in Parkinson´s disease. First results.

    A. García-Bustillo, A. Olivares-Gil, JL. Garrido-Labrador, JM. Ramírez-Sanz, A. Arnaiz-González, F. Valiñas-Sieiro, M. Allende-Río, JJ. González-Bernal, J. González-Santos, JF. Díez-Pastor, M. Jahouh, JM. Trejo-Gabriel-Galán, E. Cubo (Burgos, Spain)

    Objective: To evaluate the results of feasibility and effectiveness of multidisciplinary home-telehealth intervention program to reduce falls and improve quality of life in patients with…
  • 2022 International Congress

    Diagnosed and Drug-Treated Prevalence of Essential Tremor in Pediatric Patients: Retrospective Analyses of Two US Healthcare Claims Databases

    R. Saad, M. Markowitz, L. Gibbs, D. F, W. Ni, R. Pahwa, K. Lyons, M. Baladi, J. Lin (Palo Alto, USA)

    Objective: Estimate the prevalence of diagnosed and drug-treated essential tremor (ET) in the pediatric population using 2 US healthcare claims databases. Background: An ET diagnosis…
  • 2022 International Congress

    Perceptions of persons with Parkinson’s disease towards telemedicine as an alternative mode of consultation: An International Pre-Implementation Survey

    O. Ojo, N. Okubadejo, J-H. Ahn, J. Youn, A. Shalash, E. Hamid, A. Cardozo, A. Garcia-Bustillo, Z. Mari, M. Spindler, E. Cubo (Idi-araba, Nigeria)

    Objective: To assess the preferences and perceptions of persons living with Parkinson’s disease (PD) towards virtual consultations as an option for out-patient consultations. Background: Global…
  • 2022 International Congress

    Towards a Machine Learning Based Classification System for Hyperkinetic Movement Disorders: Generating a Neurophysiological Feature Set

    E. V.D. Brandhof, S. V.D. Veen, G. Russo, I. Tuitert, J. Dalenberg, M. V.D. Stouwe, J. Elting, M. Biehl, M. de Koning-Tijssen (Groningen, Netherlands)

    Objective: Generating a set of significant neurophysiological features to build a machine learning based diagnostic system for hyperkinetic movement disorders. Background: Hyperkinetic movement disorders cause…
  • « Previous Page
  • 1
  • …
  • 668
  • 669
  • 670
  • 671
  • 672
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley